Data availability
The data supporting the findings of this study are available from the corresponding author upon reasonable request.
References
Woyach JA, Ruppert AS, Heerema NA et al (2018) Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med 379:2517–2528
Byrd JC, Woyach JA, Furman RR et al (2021) Acalabrutinib in treatment-naive chronic lymphocytic leukemia. Blood 137:3327–3338
Byrd JC, Hillmen P, Ghia P et al (2021) Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: Results of the first randomized phase III trial. J Clin Oncol 39:3441–3452
Cheng L, Huang M, Wei J, Xu H, Zhou M, Jiang L (2022) Complete resolution of chylothorax with ibrutinib in chronic lymphocytic leukemia: a case report. Ann Palliat Med 11:1833–1837
Ebinama U, Wilson NR, Ghosh A, George BS (2022) Therapeutic management of chronic lymphocytic leukemia presenting with recurrent massive ascites. Curr Oncol 29:6787–6793
Gustine JN, Meid K, Hunter ZR, Xu L, Treon SP, Castillo JJ (2018) MYD88 mutations can be used to identify malignant pleural effusions in Waldenstrom macroglobulinaemia. Br J Haematol 180:578–581
Barnes M, Sharma P, Kumar V, Kaell A, LiPera W (2020) Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom’s macroglobulinemia: a case report. J Med Case Rep 14:98
Rogers M, Iyengar S, Wotherspoon A, Dearden C (2015) Extramedullary haematopoiesis in chronic lymphocytic leukaemia. Br J Haematol 171:442
Ratterman M, Kruczek K, Sulo S, Shanafelt TD, Kay NE, Nabhan C (2014) Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012. Leuk Res 38:299–303
Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D (2004) Pleural effusions in hematologic malignancies. Chest 125:1546–1555
Acknowledgements
We express our profound gratitude to all the doctors, nurses, and other healthcare professionals at Yokohama Municipal Citizen's Hospital for providing dedicated patient care.
Funding
No funding was received for this manuscript.
Author information
Authors and Affiliations
Contributions
Shuhei Kurosawa drafted the manuscript. Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, and Tomonori Nakazato provided patient care and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Informed consent
The patient provided written informed consent for the publication of this article.
Competing interests
No conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kurosawa, S., Yokota, T., Takada, Y. et al. Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Ann Hematol 103, 1779–1781 (2024). https://doi.org/10.1007/s00277-024-05721-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-024-05721-z